Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 3
Review
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,210 | Dovepress* | 9,263+ | 1,952 | 11,215 | |
| PubMed Central* | 2,947 | 1,135 | 4,082 | ||
| Totals | 12,210 | 3,087 | 15,297 | ||
| *Since 21 September 2016 | |||||
View citations on PubMed Central and Google Scholar